Clinical trial

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

NCT00379405 · Germans Trias i Pujol Hospital, Other · Completed

Key facts

NCT number NCT00379405
Title Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment
Official title Open-label, Comparative and Randomised Pilot Study to Evaluate the Efficacy and Safety of Saquinavir/Ritonavir in Single Therapy vs Standard HAART Therapy as Maintenance Therapy.
Lead sponsor Germans Trias i Pujol Hospital, Other
Collaborators Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Status Completed
Phase Phase 4
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Saquinavir/Ritonavir : 2 capsules (500 mg) / 12 hours
Enrollment 30
Start date Jun 1, 2006
Primary completion May 1, 2008
Completion Jul 1, 2008
First posted Sep 21, 2006
Last update posted Dec 4, 2019
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies